Overcoming immunologic incompatibility: Transplanting the difficult to transplant patient

Seminars in Dialysis

Volumn 18, Issue 6, 2005, Pages 474-481

  Crew, R John ^a   Ratner, Lloyd E ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; METHODOLOGY; REVIEW;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TRANSPLANTATION CONDITIONING;

EID: 30744475438     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.00092.x     Document Type: Review

References (54)

1. Zachary AA, Steinberg AG, Bias WB, Leffell MS: The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry. Transplantation 62:272-283, 1996
2. Sautner T, Gnant M, Banhegyi C, Wamser P, Gotzinger P, Steininger R, Muhlbacher F: Risk factors for development of panel reactive antibodies and their impact on kidney transplantation outcome. Transpl Int 5(suppl 1):S116-S120, 1992
3. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB: Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13:779-787, 2002
4. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 5(4 pt 2):904-915, 2005
5. 2004 OPTN/SRTR Annual Report. Available at http://www.ustransplant.org/ annual_reports/2004/home.aspx?f=/default.htm
6. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B: Effect of waiting time on renal transplant outcome. Kidney Int 58:1311-1317, 2000
7. Patel R, Mickey MR, Terasaki PI: Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med 279:501-506, 1968
8. Terasaki PI, Mickey MR, Singal DP, Mittal KK, Patel R: Serotyping for homotransplantation. XX. Selection of recipients for cadaver donor transplants. N Engl J Med 279:1101-1103, 1968
9. Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 3:1488-1500, 2003
10. Fuller TC, Fuller AA, Golden M, Rodey GE: HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure. Hum Immunol 56:94-105, 1997
11. Kerman RH, Van Buren CT, Lewis RM, DeVera V, Baghdahsarian V, Gerolami K, Kahan BD: Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 49:52-56, 1990
12. Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, Pochinco D, Birk P, Nickerson P: Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12:2807-2814, 2001
13. Kerman RH, Susskind B, Buyse I, Pryzbylowski P, Ruth J, Warnell S, Gruber SA, Katz S, Van Buren CT, Kahan BD: Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 68:1855-1858, 1999
14. Scornik JC, Clapp W, Patton PR, Van der Werf WJ, Hemming AW, Reed AI, Howard RJ: Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive. Transplantation 71:1098-1102, 2001
15. Cho YW, Cecka JM: Crossmatch tests - an analysis of UNOS data from 1991 to 2000. In: Cecka M, Terasaki PI, eds. Clinical Transplants. Los Angeles: UCLA Press, 2001:237-246
16. Nickeleit V, Mihatsch MJ: Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 18:2232-2239, 2003
17. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmuller G, Land W, Albert E: Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43:1333-1338, 1993
18. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3:708-714, 2003
19. Pascual M, Saidman S, Tolkoff-Rubin N, Williams WW, Mauiyyedi S, Duan JM, Farrell ML, Colvin RB, Cosimi AB, Delmonico FL: Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 66:1460-1464, 1998
20. Lobo PI, Spencer CE, Stevenson WC, Pruett TL: Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin. Transplantation 59:357-360, 1995
21. Bohmig GA, Regele H, Exner M, Derhartunian V, Kletzmayr J, Saemann MD, Horl WH, Druml W, Watschinger B: C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 12:2482-2489, 2001
22. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, Farrell ML, Williams WW, Delmonico FL, Cosimi AB, Colvin RB, Saidman SL: Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 71:652-658, 2001
23. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70:887-895, 2000
24. White NB, Greenstein SM, Camafio AW, Schechner R, Glicklich D, McDonough P, Pullman J, Mohandas K, Boctor F, Uehlinger J, Tellis V: Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 78:772-774, 2004
25. Lennertz A, Fertmann J, Thomae R, Illner WD, Hillebrand GE, Feucht HE, Land W, Samtleben W, Bosch T: Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases. Ther Apher Dial 7:529-535, 2003
26. Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN, Smith SR: Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 75:1490-1495, 2003
27. Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66:800-805, 1998
28. Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS: Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 77:1399-1405, 2004
29. Becker YT, Becker BN, Pirsch JD, Sollinger HW: Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 4:996-1001, 2004
30. Luke PP, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain A, Somani A, Fedorek S, Randhawa P, Shapiro R: IVIG rescue therapy in renal transplantation. Transplant Proc 33:1093-1094, 2001
31. Jordan S, Cunningham-Rundles C, McEwan R: Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 3:653-664, 2003
32. Casadei DHCR, Opelz G, Golberg JC, Argento JA, Greco G, Guardia OE, Haas E, Raimondi EH: A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 71:53-58, 2001
33. Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC: Post-transplant therapy with high-dose intravenous gammaglobulin: applications to treatment of antibody-mediated rejection. Pediatr Transplant 9:155-161, 2005
34. Tyan DB, Li VA, Czer L, Trento A, Jordan SC: Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 57:553-562, 1994
35. Jordan SC, Vo A, Bunnapradist S, Toyoda M, Peng A, Puliyanda D, Kamil E, Tyan D: Intravenous immune globulin treatment inhibits cross-match positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76:631-636, 2003
36. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J: Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15:3256-3262, 2004
37. Zachary AA, Montgomery RA, Ratner LE, Samaniego-Picota M, Haas M, Kopchaliiska D, Leffell MS: Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76:1519-1525, 2003
38. Schweitzer EJ, Wilson JS, Fernandez-Vina M, Fox M, Gutierrez M, Wiland A, Hunter J, Farney A, Philosophe B, Colonna J, Jarrell BE, Bartlett ST: A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 70:1531-1536, 2000
39. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, Larson TS, Griffin MD, Textor SC, Velosa JA, Schwab TR, Fix LA, Stegall MD: Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3:1017-1023, 2003
40. Stegall MD, Dean PG, Gloor JM: ABO-incompatible kidney transplantation. Transplantation 78:635-640, 2004
41. Schnuelle P, van der Woude FJ: Should A2 kidneys be transplanted into B or O recipients? Lancet 351:1675-1676, 1998
42. Nelson PW, Shield CF 3rd, Muruve NA, Murillo D, Warady BA, Aeder MI, Bryan CF: Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant 2:94-99, 2002
43. Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, Grande JP, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Velosa JA, Textor SC, Platt JL, Stegall MD: ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75:971-977, 2003
44. Alexandre GP, Squifflet JP, De Bruyere M, Latinne D, Reding R, Gianello P, Carlier M, Pirson Y: Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 19:4538-4542, 1987
45. Takahashi K, Saito K, Takahara S, Okuyama A, Tanabe K, Toma H, Uchida K, Hasegawa A, Yoshimura N, Kamiryo Y, Japanese ABO-incompatible Kidney Transplantation Committee: Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4:1089-1096, 2004
46. Galili U: Immune response, accommodation, and tolerance to transplantation carbohydrate antigens. Transplantation 78:1093-1098, 2004
47. Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, Shirey RS, Simpkins CE, Montgomery RA: Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4:1315-1322, 2004
48. Tyden G, Kumlien G, Fehrman I: Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 76:730-731, 2003
49. Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I: ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5:145-148, 2005
50. Warren DS, Zachary AA, Sonnenday CJ, King KE, Cooper M, Ratner LE, Shirey RS, Haas M, Leffell MS, Montgomery RA: Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 4:561-568, 2004
51. Terasaki PI, Gjertson DW, Cecka JM: Paired kidney exchange is not a solution to ABO incompatibility. Transplantation 65:291, 1998
52. Delmonico FL, Morrissey PE, Lipkowitz GS, Stoff JS, Himmelfarb J, Harmon W, Pavlakis M, Mah H, Goguen J, Luskin R, Milford E, Basadonna G, Chobanian M, Bouthol B, Lorber M, Rohrer RJ: Donor kidney exchanges. Am J Transplant 4:1628-1634, 2004
53. Ross LF, Zenios S: Practical and ethical challenges to paired exchange programs. Am J Transplant 4:1553-1554, 2004
54. Ross LF, Zenios S: Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit. Transplantation 78:641-646, 2004